Pharmaceutical News

Red Flags Ignored, DEA Says

[Wall Street Journal] 2012-02-21
Egypt Eyed as Possible Source of Fake Avastin

[Wall Street Journal] 2012-02-21
Gilead Tumbles as Some Hepatitis C Patients Relapse After Drug Treatment

[Bloomberg] 2012-02-17
U.S. to Review Diet Treatment Once Rejected

[New York Times] 2012-02-17
Drugmakers Vie for Piece of Future Hepatitis C Combo Pill

[Bloomberg] 2012-02-16
Fakes Infiltrate Injectable Drugs

[Wall Street Journal] 2012-02-16
Roche Says Counterfeit Cancer Drug Avastin Being Investigated by U.S. FDA

[Bloomberg] 2012-02-16
Pharmacies Swept Into Drug Wars

[Wall Street Journal] 2012-02-15
Dilemma: When 1 Drug Treats 2 Diseases

[Wall Street Journal] 2012-02-14
New Drug Approved to Treat Glaucoma

[Wall Street Journal] 2012-02-14
Drugmaker Rebates Would Rise $156B in Obama Budget

[Bloomberg] 2012-02-14
FDA budget stays about the same at $2.5 billion

[Washington Post] 2012-02-14
More generic drug use could lead to $1B savings

[Buffalo Business First] 2012-02-13
Supply of a Cancer Drug May Run Out Within Weeks

[New York Times] 2012-02-13
Pharma research group suggests the need for communication clarity

[Philadelphia Inquirer] 2012-02-10
WellPoint to Cease Branded Lipitor Coverage, Favor Generics

[Wall Street Journal] 2012-02-10
AstraZeneca Loses Ruling Over 2018 and 2021 Crestor Patents

[Bloomberg] 2012-02-10
Merck says hepatitis pill hampers HIV Drugs

[Reuters] 2012-02-10
U.S. Releases Draft Guidelines for Generic Biologic Drugs

[Bloomberg] 2012-02-10
Generic Drugs Easing Out-of-Pocket Medical Costs in U.S.

[Health Day] 2012-02-09

Managed Care Poll

Call for Bloggers

We are looking for the views and opinions of the key thought leaders in managed care and healthcare reform to include in our new blog section. We will include a link back to your Web site to help increase your visibility in this rapidly changing environment, and our readers will benefit from your expertise.

To post your blog on firstreportnow.com, click here.